Cigna Corp vs Super Micro Computer Inc — how do they compare? Cigna Corp trades at $272.72 (market cap $73.56B), while Super Micro Computer Inc trades at $34.08 (market cap $20.35B). The key difference: Cigna Corp is far larger — about 3.6× Super Micro Computer Inc's market cap, and Cigna Corp pays a 2.24% dividend while Super Micro Computer Inc pays none. Which is the better fit depends on your goals.
| CI | SMCI | |
|---|---|---|
Market Cap | $73.56B | $20.35B |
Sector | Health | Technology |
52-Week High | $311.00 | $58.68 |
52-Week Low | $244.41 | $20.53 |
Enterprise Value | $98.27B | $27.87B |
Dividend Yield | 2.24% | — |
Signals from Pluang's Aura AI — not financial advice
Cigna (CI) trades at $282.49, up 2.63% with strong earnings beats in recent quarters. The stock shows bearish technical signals but benefits from low valuation ratios like a P/E of 11.68 and P/S of 0.27. Recent Q2 2026 results exceeded expectations, with EPS of $7.78 beating estimates, and the company raised its full-year guidance to at least $30.45 adjusted EPS, reflecting robust growth in health services and insurance segments.
The outlook is positive due to consistent earnings outperformance and raised guidance, though technical weakness and competitive pressures pose risks. Analyst consensus is strongly bullish with a $338.90 price target, indicating ~20% upside potential from current levels, supported by dividend payments and institutional accumulation.
Super Micro Computer (SMCI) trades at $31.13, up 5.96% on the day, with a bullish technical signal from moving averages. The stock shows strong fundamental metrics with a P/E of 16.56 and P/S of 0.62, while recent earnings have beaten expectations. Revenue growth remains robust, reaching $21.97B in 2025, though net margins compressed to 3.7%. Analyst consensus is mixed with a $39.20 price target, representing 26% upside potential from current levels.
The outlook for SMCI hinges on execution of its massive $60B AI server order backlog and margin expansion to 15-17% guidance. Key risks include working capital strain with negative operating cash flow projected for 2026 and high dependence on Nvidia components. While valuation appears attractive, investors should monitor the company's ability to convert orders into profitable growth amid intense AI infrastructure competition.
Trailing returns across standard periods
Latest headlines on both assets
Cigna primarily provides pharmacy benefit management and health insurance services. Its PBM services were greatly expanded by its 2018 merger with Express Scripts and are mostly sold to health insurance plans and employers. Its largest PBM contract is the Department of Defense. In health insurance and other benefits, Cigna mostly serves employers through self-funding arrangements, but it also operates in government programs, such as Medicare Advantage. The company operates mostly in the U.S. with 15 million medical members covered as of the end of 2020, but its services extend internationally, covering another 2 million people.
Read more on CI →Super Micro Computer, Inc., commonly known as Supermicro, is a leading provider of high-performance and high-efficiency server technology and innovation. The company specializes in designing, manufacturing, and selling advanced server, storage, and networking solutions, primarily for data centers, cloud computing, artificial intelligence, and 5G/Edge computing markets. SMCI's modular architecture allows for the rapid delivery of customized and purpose-built solutions, making it a key player in the enterprise computing and specialized AI infrastructure space.
Read more on SMCI →